ProQR Research Development History
| PRQR Stock | USD 1.71 -0.01 -0.58% |
Research Development | First Reported 2012-12-31 | Previous Quarter 11.1 M | Current Value 9.8 M | Quarterly Volatility 3.5 M |
Macro event markers
Looking at ProQR Therapeutics's Research Development across several periods shows whether the company is sustaining progress or losing momentum. This longer view catches turning points and structural changes that a single quarter of ProQR Therapeutics BV data cannot reveal.
Latest ProQR Therapeutics' Research Development Growth Pattern
ProQR Therapeutics BV's Research Development is charted below. The chart below tracks ProQR Therapeutics' Research Development to show whether it is rising, falling, or flat over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Research Development Trend Statistics
| Arithmetic Mean | 26,002,147 | |
| Geometric Mean | 12,491,222 | |
| Coefficient Of Variation | 65.62 | |
| Mean Deviation | 14,059,062 | |
| Median | 31,153,000 | |
| Standard Deviation | 17,062,406 | |
| Sample Variance | 291.1T | |
| Range | 50.5M | |
| R-Value | 0.81 | |
| Mean Square Error | 108.5T | |
| R-Squared | 0.65 | |
| Significance | 0.000092 | |
| Slope | 2,725,373 | |
| Total Sum of Squares | 4658T |
ProQR Research Development History
Related Accounts
| Last Reported | End Of Year Estimate | ||
| Research Development | 40.7 M | 32.1 M |
Methodology, Assumptions & Data Sources
ProQR Therapeutics's Research Development trend is shown across available quarters. A sustained rise or fall can shape how analysts think about the stock.
Inputs for ProQR Therapeutics BV come from periodic company reporting and market reference feeds and are mapped into a consistent schema for analysis. Some fields can appear with publication lag. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.